Frank Jaeger - Dec 11, 2021 Form 4 Insider Report for Clarus Therapeutics Holdings, Inc. (CRXT)

Role: Chief Commercial Officer
Signature: /s/ Steven A. Bourne, attorney-in-fact
Stock symbol: CRXT
Transactions as of: Dec 11, 2021
Transactions value $: $0
Form type: 4
Date filed: 12/14/2021, 06:02 PM
Previous filing: Sep 13, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CRXT	Common Stock	Award	$0	+29K		$0.00	29K	Dec 11, 2021	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CRXT	Stock Option (Right to Buy)	Award	$0	+72.5K		$0.00	72.5K	Dec 11, 2021	Common Stock	72.5K	$4.78	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The Reporting Person was granted a Restricted Stock Unit under the Issuer's 2021 Stock Option and Incentive Plan (the "2021 Plan") for 29,000 shares on 12/11/2021, of which 25% vest on 9/9/2022, and the remaining shares vest in 36 equal monthly installments thereafter subject to the Reporting Person continuing to have a service relationship as of each such vesting date.
F2	These options were granted under the 2021 Plan and vest (i) 25% on 9/9/2022 and (ii) with the remainder vesting in 36 equal monthly installments thereafter subject to the Reporting Person continuing to have a service relationship as of each such vesting date.